Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis-Reference-Cited by-同舟云学术

Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis

Published:2018-08-23 Issue:8 Volume:14 Page:e1007264
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Zakaria Chadi,Sean Polen,Hoang Huy-Dung,Leroux Louis-Phillipe^ORCID,Watson Margaret,Workenhe Samuel Tekeste,Hearnden Jaclyn,Pearl Dana,Truong Vinh Tai,Robichaud Nathaniel^ORCID,Yanagiya Akiko,Tahmasebi Soroush,Jafarnejad Seyed Mehdi,Jia Jian-Jun,Pelin Adrian,Diallo Jean-Simon^ORCID,Le Boeuf Fabrice^ORCID,Bell John Cameron,Mossman Karen Louise^ORCID,Graber Tyson Ernst^ORCID,Jaramillo Maritza,Sonenberg Nahum,Alain Tommy^ORCID

Funder

Terry Fox Research Institute

Canadian Cancer Society Research Institute (CA)

Cancer Research Society

Brain Tumour Foundation of Canada (CA)

CHEO Foundation

Terry Fox Research Institute (CA)

Natural Sciences and Engineering Research Council of Canada

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology